Health & Wellness focused brand Kapiva bags $10 million from existing investors
Homegrown D2C ayurvedic nutrition brand Kapiva has raised Rs.83.5 crore or nearly about $10 million, led by OrbiMed Asia, with participation from 3One4 Capital and Vertex Ventures.
Kapiva's board has approved a special resolution to issue 5,62,631 compulsory convertible preference shares to secure the raised amount, according to a regulatory filing obtained from the Registrar of Companies.
Homegrown D2C ayurvedic nutrition brand Kapiva has raised Rs. 83.5 crore or about $10 million, led by OrbiMed Asia, with participation from 3One4 Capital and Vertex Ventures.
Kapiva's board has approved a special resolution to issue 5,62,631 compulsory convertible preference shares to secure the raised amount, according to a regulatory filing obtained from the Registrar of Companies.
Kapiva has expanded its ESOP pool by adding 1,415,000 new employee stock options, increasing the total to 4,47,741, according to a separate filing. Estimates from Entrackr suggest that the current value of its ESOP pool is around Rs. 66 crore.
The company plans to use the funds for expansion and development. To date, Kapiva has raised over $30 million and counts notable investors such as Jetty Ventures, Fireside, OrbiMed, and 3One4 Capital among its backers.
According to data from the startup intelligence platform TheKredible, the company's post-allotment valuation is approximately $80 million.
Founded in 2015, Kapiva is an ayurvedic nutrition brand that offers a range of natural and organic health and skincare products targeting issues like hair fall, weight loss, digestion, and diabetes, available in formats such as juices, teas, oils, and shakes.
During the fiscal year of that ended in March 2023, Kapiva has recorded a growth of 87% year-on-year to Rs. 116.48 crore. There parcentage of loss stuck at Rs. 64.5 crore in the same period. Kapiva hasn’t filed their annual results for FY24.
The health & wellness market in India has a bright future having so many emerging startups such as Upakarma Ayurveda, and Dr. Vaidya’s, Varalife, among others.
.jpg "Team Startupcity")
Kapiva's board has approved a special resolution to issue 5,62,631 compulsory convertible preference shares to secure the raised amount, according to a regulatory filing obtained from the Registrar of Companies.
Homegrown D2C ayurvedic nutrition brand Kapiva has raised Rs. 83.5 crore or about $10 million, led by OrbiMed Asia, with participation from 3One4 Capital and Vertex Ventures.
Kapiva's board has approved a special resolution to issue 5,62,631 compulsory convertible preference shares to secure the raised amount, according to a regulatory filing obtained from the Registrar of Companies.
Kapiva has expanded its ESOP pool by adding 1,415,000 new employee stock options, increasing the total to 4,47,741, according to a separate filing. Estimates from Entrackr suggest that the current value of its ESOP pool is around Rs. 66 crore.
The company plans to use the funds for expansion and development. To date, Kapiva has raised over $30 million and counts notable investors such as Jetty Ventures, Fireside, OrbiMed, and 3One4 Capital among its backers.
According to data from the startup intelligence platform TheKredible, the company's post-allotment valuation is approximately $80 million.
Founded in 2015, Kapiva is an ayurvedic nutrition brand that offers a range of natural and organic health and skincare products targeting issues like hair fall, weight loss, digestion, and diabetes, available in formats such as juices, teas, oils, and shakes.
During the fiscal year of that ended in March 2023, Kapiva has recorded a growth of 87% year-on-year to Rs. 116.48 crore. There parcentage of loss stuck at Rs. 64.5 crore in the same period. Kapiva hasn’t filed their annual results for FY24.
The health & wellness market in India has a bright future having so many emerging startups such as Upakarma Ayurveda, and Dr. Vaidya’s, Varalife, among others.
.jpg "Varolyn Healthcare : Transforming Patient Care with Technology, Compassion, & Innovation")
